These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9648803)

  • 1. Callback rate after screening mammography.
    Linver MN; Rosenberg RD
    AJR Am J Roentgenol; 1998 Jul; 171(1):262-3. PubMed ID: 9648803
    [No Abstract]   [Full Text] [Related]  

  • 2. Stat bite: Frequency of breast cancer screening by health plan, 2000-2003.
    J Natl Cancer Inst; 2004 Nov; 96(22):1657. PubMed ID: 15547177
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcome measures of an Australian breast-screening program.
    Rodger A; Kavanagh AM
    Med J Aust; 1998 Aug; 169(4):179-80. PubMed ID: 9734571
    [No Abstract]   [Full Text] [Related]  

  • 4. [Danish Quality Database for Mammography Screening].
    Vejborg I; Mikkelsen EM; Schwartz W; Bak M; Lernevall A; Borg Mogensen N; Garne JP
    Ugeskr Laeger; 2012 Oct; 174(42):2533. PubMed ID: 23079436
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality assurance audits of community screening mammography practices: availability of active follow-up for data collection and outcome assessment.
    Brown ML; Houn F
    AJR Am J Roentgenol; 1994 Oct; 163(4):825-9. PubMed ID: 8092017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The truth about mammography.
    Aaron JO
    J Ky Med Assoc; 1992 Jun; 90(6):305. PubMed ID: 1619350
    [No Abstract]   [Full Text] [Related]  

  • 7. Should mammography screening be promoted if quality assurance is lacking?
    Barmus B
    Public Health Rep; 1993; 108(1):135. PubMed ID: 8434090
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality assurance in Trent Regional Health Authority's breast screening programme.
    Thornhill P
    Radiogr Today; 1990 Apr; 56(635):11-3. PubMed ID: 2363814
    [No Abstract]   [Full Text] [Related]  

  • 9. [The quality of mammography scrutinized. Ongoing control mass screenings for breast cancer is necessary].
    Andersson I; Rydén S; Karlberg I
    Lakartidningen; 1995 Aug; 92(35):3106-9. PubMed ID: 7658762
    [No Abstract]   [Full Text] [Related]  

  • 10. [What is the benefit of screening for breast cancer? Contra].
    Schmidt JG
    Arch Gynecol Obstet; 1996; 259 Suppl 1():S178-98. PubMed ID: 9133272
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of roentgen mammography for breast carcinoma screening].
    Schulz-Wendtland R; Krämer S; Döinghaus K; Säbel M; Lang N; Bautz W
    Rontgenpraxis; 1997 May; 50(5):103-9. PubMed ID: 9297252
    [No Abstract]   [Full Text] [Related]  

  • 12. Mammography and clinical breast examinations among women aged 50 years and older--Behavioral Risk Factor Surveillance System, 1992.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Oct; 42(38):737-41. PubMed ID: 8371707
    [No Abstract]   [Full Text] [Related]  

  • 13. Benefits of screening mammography: a review for the primary care physician.
    Reichle JL
    South Med J; 1998 Jun; 91(6):510-7. PubMed ID: 9634110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guidelines for pathology--supplement to European guidelines for quality assurance in mammography screening. Report by the Pathology Working Group of the European Community].
    Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Böcker W; Bussolati G; Connolly CE; De Miguel C; Dervan P; Drijkoningen R; Elston CW; Faverly D; Gad A; Holland R; Jacquemier J; Lacerda M; Lindgren A; Martinez-Peñuela J; Peterse JL; Rank F; Tsakraklides V; de Wolf C; Zafrani B
    Pathologe; 1997 Jan; 18(1):71-88. PubMed ID: 9157408
    [No Abstract]   [Full Text] [Related]  

  • 15. Breast cancer--screening data for assessing quality of services--New York, 2000-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jun; 53(21):455-7. PubMed ID: 15175570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography screening rates decline: a person-time approach to evaluation.
    Feldstein AC; Vogt TM; Aickin M; Hu WR
    Prev Med; 2006 Sep; 43(3):178-82. PubMed ID: 16675004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [German Mammography Study: commission, cooperative structure, results and consequences].
    Robra BP; Swart E; Dierks ML
    Z Arztl Fortbild Qualitatssich; 1997 Sep; 91(6):541-2. PubMed ID: 9441030
    [No Abstract]   [Full Text] [Related]  

  • 18. Routine mammography screening increases except among minorities and the elderly.
    Oncology (Williston Park); 2002 Jan; 16(1):63, 123. PubMed ID: 11831611
    [No Abstract]   [Full Text] [Related]  

  • 19. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010.
    Martinez-Huedo MA; Lopez de Andres A; Hernandez-Barrera V; Carrasco-Garrido P; Martinez Hernandez D; Jiménez-Garcia R
    Diabetes Metab; 2012 Apr; 38(2):142-8. PubMed ID: 22078638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Organized breast cancer screening: experience at Bouches-du-Rhône].
    Seradour B
    Bull Acad Natl Med; 1998; 182(8):1665-7. PubMed ID: 10188312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.